What is next for this stock. Any hope?. No one is opening their mouth. Where is management of this company?. Why they are not giving any clear future path or guidelines. Seems like every one is gone for a break.
It will be like always: hovering around 20-25 cents. I do not expect any significant news any time soon. Nor do I expect that Ampligen will receive approval. But I REALLY wish for the CFS patients that they (FDA, NIH, HEB, whoever) figure sth. out to help them. Something on the short - to medium term, I mean.